SARTORIUS (UNSP.ADS)/1/5 - Asset Resilience Ratio
SARTORIUS (UNSP.ADS)/1/5 (SRT0) has an Asset Resilience Ratio of 0.26% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how SARTORIUS (UNSP.ADS)/1/5's Asset Resilience Ratio has changed over time. See SARTORIUS (UNSP.ADS)/1/5 free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down SARTORIUS (UNSP.ADS)/1/5's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SRT0 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €26.10 Million | 0.26% |
| Total Liquid Assets | €26.10 Million | 0.26% |
Asset Resilience Insights
- Limited Liquidity: SARTORIUS (UNSP.ADS)/1/5 maintains only 0.26% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SARTORIUS (UNSP.ADS)/1/5 Industry Peers by Asset Resilience Ratio
Compare SARTORIUS (UNSP.ADS)/1/5's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 4.32% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
Annual Asset Resilience Ratio for SARTORIUS (UNSP.ADS)/1/5 (2022–2025)
The table below shows the annual Asset Resilience Ratio data for SARTORIUS (UNSP.ADS)/1/5.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.11% | €10.40 Million ≈ $12.16 Million |
€9.72 Billion ≈ $11.36 Billion |
-0.04pp |
| 2024-12-31 | 0.15% | €15.30 Million ≈ $17.89 Million |
€10.10 Billion ≈ $11.81 Billion |
0.00pp |
| 2023-12-31 | 0.15% | €15.00 Million ≈ $17.54 Million |
€9.75 Billion ≈ $11.39 Billion |
-0.29pp |
| 2022-12-31 | 0.44% | €30.90 Million ≈ $36.13 Million |
€6.98 Billion ≈ $8.16 Billion |
-- |
About SARTORIUS (UNSP.ADS)/1/5
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more